Tissue Regenix (GB:TRX) has released an update.
Investor Richard Sneller has altered his stake in Tissue Regenix Group PLC, crossing a noteworthy threshold on July 3, 2024, with his voting rights reaching 15.1% of the company. This shift represents an increase from the previous notification, where Sneller held 14% of the voting rights, highlighting a significant change in shareholder composition. The update, filed in London, indicates a strategic move by Sneller, potentially impacting Tissue Regenix’s stock dynamics.
For further insights into GB:TRX stock, check out TipRanks’ Stock Analysis page.
